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West Nile virus (WNV), Japanese encephalitis virus (JEV) and tick-
borne encephalitis virus (TBEV) are ﬂaviviruses responsible for
severe neuro-invasive infections in horses and humans. The
conﬁrmation of ﬂavivirus infections is mostly based on rapid
serological tests such as enzyme-linked immunosorbent assays
(ELISA). These tests suffer from poor speciﬁcity, mainly due to
antigenic cross-reactivity among ﬂavivirus members. Robust
diagnosis therefore needs to be validated through virus neutral-
isation tests (VNT) which are time-consuming and require BSL3
facilities. The ﬂavivirus envelope (E) glycoprotein ectodomain is
composed of three domains (D), e.g. DI, DII and DIII, with EDIII
containing virus-speciﬁc epitopes. In order to improve the sero-
logical differentiation of ﬂavivirus infections, the recombinant
soluble ectodomain of WNV E (WNV.sE) and EDIIIs (rEDIIIs) of
WNV, JEV and TBEV were synthesised using the Drosophila S2
expression system. Puriﬁed antigens were covalently bonded to
ﬂuorescent beads (ﬁgure 1). The microspheres coupled with
WNV.sE or rEDIIIs were assayed with about 300 equine immune
sera from natural and experimental ﬂavivirus infections and 172
non-immune equine sera as negative controls. rEDIII-coupled
microspheres captured speciﬁc antibodies against WNV, TBEV or
JEV in positive horse sera in a ﬂavivirus multiplex immunoassay
(MIA). MIA developed for the detection of ﬂavirus infection
showed a relative sensitivity and speciﬁcity close to 99% when
compared to ﬂavivirus competition ELISA. By comparison with
VNT, ﬂavivirus MIA correctly identiﬁed the causative ﬂavivirus in
100%, 96.8% and 90.0% WNV-, TBEV- and JEV-infected horses
respectively. Several advantages plead in favour of the develop-
ment and implementation of this ﬂavivirus MIA in reference
laboratories: no need for BSL3 facilities to conﬁrm ﬂavivirus in-
fections , requirement of small sampling volumes (1 ml) as well as
analysis speed-up (< 3hours).
Figure 1. Presentation of the ﬂavivirus MIA with four beads coupled to four
antigens (WNV.sE, WNV.EDIII, JEV.EDIII and TBEV.EDIII)
107
Development of a Luminex Immunoassay for the
serological diagnosis of Vesicular Stomatitis (VS) and
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VS is a zoonotic viral disease affecting livestock. The causa-
tive agent, Vesicular Stomatitis virus (VSV), belongs to the
genus Vesiculovirus in Rhabdoviridae family. Two serotypes
have been described: New Jersey (NJ) and Indiana (IND), the
latter being subdivided into 3 subtypes (Indiana 1, 2, 3). In
cattle and pigs, VS remains clinically difﬁcult to differentiate
from foot and mouth disease (FMD) when horses are not
involved. A prompt laboratory differential diagnosis is thus
essential. Serological diagnosis is based on VNT, Complement
Fixation and ELISA. This study describes the development of a
rapid serological diagnostic test based on Luminex technol-
ogy and its comparison with the VNT and Competitive ELISA
(C ELISA). The objective is to develop a multiplex Luminex
test allowing both serotyping and differential diagnosis of
VSV. The Luminex technology is based on the principle of
ﬂow cytometry and relies on the use of ﬂuorescent micro-
spheres (“beads”) which can be coupled to biological mac-
romolecules. A batch of beads was coupled to the envelope
glycoprotein of the VSV, serotype NJ (VSV-G-NJ), produced as
recombinant antigen using the baculovirus system and
harboring a C terminus tag MAT. The coupled beads were
incubated with positive equine sera and the antigen/antibody
complexes were revealed using biotinylated anti-species
antibody and streptavidin-phycoerythrin. Results were
analyzed on the Luminex200 platform. Median ﬂuorescence
intensity (MFI) values were measured and normalized. VNT
were conducted per the OIE manual for terrestrial animals,
using the alternative protocol (virus at 100 TCID50 /25mL).
Efﬁciency of antigen/bead coupling was assessed using a
monoclonal antibody speciﬁc to the MAT tag. Speciﬁcity of
the coupling was veriﬁed using a panel of well characterized
positive bovine VSV-NJ- or VSV-IND sera. The protocol was
then optimized for equine sera. A prototype test was thus
developed, with a cut off value determined using a panel of
100 naive horse sera, in two independent experiments. This
prototype was evaluated on a panel of positive equine sera.
VNT was performed on the same panel. Results obtained
show a good correlation between Luminex, VNT and C ELISA
analyses. A ﬁrst step in developing a Luminex-based sero-
logical test for VS diagnostic was reached, using the VSV-G
protein-NJ. Similar work is underway using a recombinant
VSV-G-IND protein and a duplex test is under development.
Bead sets coupled to these VSV-G proteins may also be
combined to bead batches developed in our laboratory for
FMD serological diagnosis with the aim to offer a differential
diagnostic VS/FMD in cattle. The sensitivity and speciﬁcity of
these luminex prototypes will also be compared to those
obtained with the VNT reference method.108
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otic Lymphangitis (EZL), is endemic in parts of Africa including,
Ethiopia, Senegal and Gambia. Despite its high prevalence, impact
on animal welfare and socio-economic importance, there is little
evidence upon which to build contextually relevant disease
control programmes. The performance and availability of diag-
nostic tests currently used by clinicians is problematic. Methods
such as pattern recognition of clinical signs and microscopy lack
sensitivity, and other options are either not commercially avail-
able or not readily feasible (e.g. culture). This is a signiﬁcant
barrier to further understanding this disease within endemic
countries. This study aimed to validate a nested PCR method to
conﬁrm the presence of HCF in equine clinical samples. Ethical
approval was obtained from the University of Liverpool and the
College of Veterinary Medicine and Agriculture. Twenty-nine
horses with suspected EZL were included from topographically
varied regions of Ethiopia. Clinical examination was recorded and
lesion locations drawn onto equine silhouettes. Blood samples
and aspirates of pus from unruptured cutaneous nodules were
obtained before treatment provided by SPANA. Blood and clinical
data were collected from a further 20 horses with no cutaneous
EZL lesions. Giemsa stained impression smears of pus and blood
were examined microscopically. Aliquots of heat-inactivated pus
and blood were inoculated onto Whatman FTA cards and im-
ported to the UK with Defra approved licensing. A nested PCR
targeting the ITS region*, was used to identify samples containing
HCF, and all PCR products were sequenced. HCF was conﬁrmed in
FTA card pus samples from 24 horses, additionally, 23 blood
samples were positive from EZL suspected cases. The nested PCR
compared favourably overmicroscopic examination of pus, where
characteristic HCF yeast bodies were detected in only 14 of the 24
PCR positive samples examined. All nested PCR ampliﬁcation
products were conﬁrmed as Histoplasma spp. by sequencing.
Sequencing of cloned PCR amplicons suggested at least two sub-
groups of HCF based on single nucleotide polymorphisms. These
techniques allow the rapid diagnosis of HCF directly from equine
clinical samples and offer a useful epidemiological tool. The
identiﬁcation of HCF in blood raises questions about the patho-
genesis of HCF in horses and warrants further investigation.
*Jiang, B. et. al. (2000) Journal of clinical microbiology 38 (1): 241-
245.
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A novel molecular diagnostic tool for Equine Arteritis
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versity, USAEquine arteritis virus (EAV) is a member of the Arteriviridae
family. EAV infects equidae and can persist in the reproductive
tract of stallions only. Stallions persistently infected shed the virus
in their semen and spread the virus in the horse population
during breeding. Moreover, infection may cause abortion in
pregnant mares and the death of young foals. OIE prescribes viral
isolation (VI) on cell culture to detect EAV for international trade.
However, a recent study showed that the real-time reverse
transcription-PCR (RT-qPCR) assay is as sensitive as VI for
detecting EAV in semen [1]. The main challenge to EAV surveil-
lance is detecting EAV to prevent costly outbreaks, considering in
particular the limited number of viral nucleotides targeted, in
some samples. The aim of our studywas to increase the sensitivity
of the OIE-recommended RT-qPCR method by combining it with
an unbiased ampliﬁcation method using the Phi29 polymerase
coupled to a high-density resequencing microarray (RMA) to
genotype the viruses detected. Sixty different samples were used
in this study. Of the 48 EAV-positive samples, 31 were from
semen, 12 were from virus isolation cell culture supernatants and
ﬁve were tissue samples from the lungs, spleen or liver of one
aborted foetus, three young foals and an adult. Our results
showed that isothermal ampliﬁcation polymerase signiﬁcantly
increased the ratio of ampliﬁcation from a factor ranging from 102
to 107 compared to the OIE-recommended RT-qPCR method [2].
To genotype the viruses detected, we combined the unbiased
ampliﬁcation of nucleic acids with a RMA. The two EAV sequences
tiled on the microarray cover a region located in ORF 1 coding for
the non-structural protein 9. Surprisingly, the phylogenic tree
obtained with the nsp 9 nucleotide sequences retrieved from the
microarray was able to separate strains into the NA and EU groups
and divided the EU group into subgroups EU-1 and EU-2 [2]. In
conclusion, this method can be recommended for the detection of
EAV in semen and aborted foetuses, especially when viral load is
very low. In addition, this study conﬁrmed and validated the
usefulness of the high-density resequencing DNA microarray for
both the diagnosis of equine viral diseases and the genotyping of
RNA viruses such as equine arteritis virus.
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EP is a tick-borne infection, caused by T. equi and B. caballi.
Affected animal presents non-speciﬁc signs while introduction of
the infection in free areas is due to the movement of inapparent
carriers. Laboratory diagnosis of EP is generally requested for the
conﬁrmation of clinical suspects and sanitary certiﬁcation of an-
imals for trade. OIE-prescribed tests are serological methods i.e.
ELISA and indirect immunoﬂuorescence (IFAT). Even practitioners
mostly request only serological tests for conﬁrmation of suspect
